Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Patricia learned early in her career that nothing creative can grow in a negative working environment. But she didn’t let that stand in her way. Now a leader in academia, she is determined to play her part in changing that culture.

Patricia Kingori smiling outdoors

Patricia's research career nearly stalled halfway through her PhD.

Civil unrest had forced her to leave Kenya, where she was doing her fieldwork, at short notice. That put her under pressure to work out how to continue her research. 

"Everything started to feel like it was falling apart. Kenya was the main location for my PhD and it didn’t look like I was going to be able to go back safely." 

She was also pregnant with her second child – and felt unsupported at work.

"My time away on maternity leave had really been seen as writing me off. ‘That’s it now, we might never see her again,’ that kind of attitude. I found that very difficult.

This wasn’t what Patricia had expected from her PhD. She’d hardly rushed into it – for eight years she’d worked as a research assistant and then as a research fellow at two London universities.

Read the full story (Wellcome Trust website)

Similar stories

Oxford-led team given £6.6m to map uncharted networks in the progression of Parkinson’s

A major new $9 million (£6.6 million) project funded by the Aligning Science Across Parkinson’s (ASAP) initiative will map the original circuits vulnerable to Parkinson’s on an unprecedented scale. It is the only UK-led ASAP project this year, and the first ever to be led by Oxford.

Tamoxifen repurposing study shows no benefit in treating deadly fungal meningitis

Hopes that tamoxifen could improve survival for a deadly form of fungal meningitis have been dashed by the results of a clinical trial conducted by University of Oxford researchers and published today in eLife.

Oxford researchers awarded funding to complete community COVID-19 antiviral trial

Researchers from the Nuffield Department of Primary Care Health Sciences, University of Oxford, have today announced that they have been awarded funding through the National Institute for Health Research (NIHR) to work with several UK universities and carry out a first-of-its-kind clinical trial, testing novel antiviral COVID-19 treatments for use early on in the illness by people in the community with COVID-19 who are at higher risk of complications.

New therapeutic targets identified to treat inflammatory bowel disease

Millions of patients with ulcerative colitis or Crohn’s disease, collectively known as inflammatory bowel disease (IBD), are given fresh hope as a new study shows why some of them do not respond to current treatments.

Oxford researchers call for an urgent re-evaluation of “weak” opioid safety profile

A new study associates dispensation doses of tramadol with increased risk of mortality, cardiovascular events, and fractures compared to the use of codeine to treat pain.

Labelling proteins through the diet gives new insights into how collagen-rich tissues change as we age

A new study, published in eLife, uses advanced tissue analysis technology to show how the incorporation of new proteins changes in bone and cartilage with age.